We are live on
!
Find out more
Syndax Pharmaceuticals
SNDX
SNDX
166 hedge funds and large institutions have $1.48B invested in Syndax Pharmaceuticals in 2023 Q2 according to their latest regulatory filings, with 23 funds opening new positions, 83 increasing their positions, 42 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
98% more repeat investments, than reductions
Existing positions increased: 83 | Existing positions reduced: 42
21% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 19
2% more funds holding
Funds holding: 163 → 166 (+3)
4% less capital invested
Capital invested by funds: $1.54B → $1.48B (-$61.9M)
3.97% less ownership
Funds ownership: 106.65% → 102.67% (-4%)
13% less funds holding in top 10
Funds holding in top 10: 8 → 7 (-1)
52% less call options, than puts
Call options by funds: $2.23M | Put options by funds: $4.69M
Holders
166
Holders Change
+3
Holders Change %
+1.84%
% of All Funds
2.61%
Holding in Top 10
7
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-12.5%
% of All Funds
0.11%
New
23
Increased
83
Reduced
42
Closed
19
Calls
$2.23M
Puts
$4.69M
Net Calls
-$2.46M
Net Calls Change
-$936K
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$17M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$14.8M |
| 3 |
WP
Woodline Partners
San Francisco,
California
|
+$12.7M |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$10.6M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
+$9.89M |
Top Sellers
| 1 |
BI
BVF Inc
San Francisco,
California
|
-$45.3M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$28M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$20.7M |
| 4 |
B
Braidwell
Stamford,
Connecticut
|
-$19.4M |
| 5 |
Barclays
London,
United Kingdom
|
-$16.9M |
